Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.48 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.48 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3941637 | 0.83 | ACE2 (0.43) | CARM1PRMT6PRMT8SIGMAR1ACE2 | |
| SCHEMBL22781755 | 0.82 | HRH3 (0.56) | SIGMAR1ALDH1A1HRH3 | |
| SCHEMBL3941978 | 0.81 | ALDH1A1 (0.47) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL7342049 | 0.80 | CARM1 (0.46) | CARM1PRMT6PRMT8DPP7SIGMAR1 | |
| SCHEMBL10410535 | 0.80 | CARM1 (0.62) | CARM1PRMT6PRMT8DPP7SIGMAR1 | |
| SCHEMBL3730331 | 0.78 | CARM1 (0.45) | CARM1PRMT6PRMT8DPP7SIGMAR1 | |
| SCHEMBL31326654 | 0.78 | CARM1 (0.59) | CARM1PRMT6PRMT8DPP7SIGMAR1 | |
| SCHEMBL22788741 | 0.78 | CARM1 (0.59) | CARM1PRMT6PRMT8DPP7SIGMAR1 | |
| SCHEMBL17528553 | 0.78 | CARM1 (0.59) | CARM1PRMT6PRMT8DPP7SIGMAR1 | |
| SCHEMBL4288469 | 0.78 | CARM1 (0.59) | CARM1PRMT6PRMT8DPP7SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029811-A1 | N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres | DIVERDRUGS, S.L. (ES) | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029811-A1 | N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres | GRM1, GRM2, GRIN1 | CARM1 707/4885PRMT6 766/4885PRMT8 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.